Literature DB >> 4898982

Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

M R Venneman, N J Bigley.   

Abstract

Ribosomal preparations obtained from Salmonella typhimurium by differential centrifugation and sodium dodecyl sulfate (SDS) treatment of the bacillary lysate were found to be immunogenic in F(1) hybrid (C(3)H/HeJ x DBA/2J) and albino Swiss mice, as determined by progressive host survival. The immunity obtained was independent of the need for adjuvant and dependent on the dosage of immunogen given. Immunizations with the ribosomal preparations induced an immune response comparable to that obtained by vaccination with living organisms and significantly greater than that obtained by immunization with heat-killed salmonellae, purified lipopolysaccharide, or crude and SDS-treated endotoxin preparations. No effect on the immunogenicity of the ribosomal fraction was observed by enzymatic treatment with trypsin, Pronase, deoxyribonuclease, and pancreatic ribonuclease. Linear sucrose density gradient resolution of the preparations showed that the immunogenicity of the ribosomal fraction was not unique to any one of its subcomponents. Ethyl alcohol-precipitated, crude ribonucleic acid preparations obtained from the ribosomal and sucrose density-resolved ribosomal preparations were found to induce an immune response comparable to that obtained by immunization with the entire ribosomal fraction. Dialysis in doubly distilled demineralized water slightly reduced the immunogenicity of the preparation; however, comparable dialysis in 10(-4)m MgCl(2)-phosphate buffer did not. Chemical assays of the preparations found to be immunogenic were performed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4898982      PMCID: PMC315369          DOI: 10.1128/jb.100.1.140-148.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  25 in total

1.  PARTIAL PURIFICATION OF THE "PROTECTIVE" ANTIGEN OF SALMONELLA TYPHIMURIUM AND ITS DISTRIBUTION AMONGST VARIOUS STRAINS OF BACTERIA.

Authors:  C R JENKIN; D ROWLEY
Journal:  Aust J Exp Biol Med Sci       Date:  1965-02

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Interaction between Salmonella typhimurium and phagocytic cells in cell culture.

Authors:  G FURNESS
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

4.  Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice.

Authors:  F M Collins; G B Mackaness
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

5.  Effect of chloramphenicol on the synthesis and stability of ribonucleic acid in Bacillus subtilis.

Authors:  R A Lazzarini; E Santangelo
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

6.  Properties and fine structure of the ribosomes from Mycobacterium tuberculosis.

Authors:  A Worcel; D S Goldman; I B Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

Review 7.  Biodynamic effects of oligonucleotides.

Authors:  W Braun; W Firshein
Journal:  Bacteriol Rev       Date:  1967-06

8.  Heat-labile antigens of Salmonella enteritidis. II. Mouse-protection studies.

Authors:  F M Collins; M Milne
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

9.  NATURE OF THE LABILE IMMUNOGENIC SUBSTANCE IN THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

10.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  43 in total

1.  New test for endotoxin potency based upon histamine sensitization in mice.

Authors:  R K Bergman; K C Milner; J J Munoz
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

3.  Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

Authors:  G Bachrach; M Banai; S Bardenstein; G Hoida; A Genizi; H Bercovier
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

5.  Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

6.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

7.  The immunogenic activity of ribosomal fractions derived from Brucella abortus.

Authors:  M J Corbel
Journal:  J Hyg (Lond)       Date:  1976-02

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Effect of erythrocytes treated with enterobacterial common antigen on experimental Salmonella typhimurium infection of mice.

Authors:  E A Gorzynski; S A Krasny
Journal:  Med Microbiol Immunol       Date:  1975-07-02       Impact factor: 3.402

10.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.